LIVERACE EXPLAINS PBC TO KIDS; ANIMATED SCIENCE EDUCATION WITH HEART
SHR partnered with a leading liver disease advocacy organization to help children understand Primary Biliary Cholangitis in a way that felt safe, age-appropriate, and reassuring. Through an animated character and empathy-led storytelling, we translated complex science into language children could grasp—supporting emotional understanding, family communication, and a sense of calm during uncertainty.
THE BENEFIT OF ORAL, AT-HOME TREATMENT
SHR partnered with a precision oncology biotech to illustrate the real-world impact of an oral therapy designed for at-home treatment. Through a patient-centered video filmed in a calm, everyday setting, we contrasted the emotional and physical toll of hospitalization with the dignity, comfort, and autonomy of receiving care at home—highlighting not only clinical value, but meaningful improvements in quality of life.
FROM INSIGHT TO IMPACT—TRANSFORMING PATIENT UNDERSTANDING FOR A GROWING BIOTECH COMPANY
For a growing biotechnology company, SHR helped transform internal understanding of a precision oncology therapy by centering the patient experience. Through a real patient story, we bridged complex science with lived reality—strengthening empathy, reinforcing a Patients First culture, and deepening internal engagement across sales and medical affairs. The work led to sustained storytelling partnerships and expanded use across internal and external communications.
BREAKING BARRIERS IN PEDIATRIC CANCER RESEARCH
SHR partnered with a biotechnology innovator to tell the story behind a bold decision: including children as young as one year old in precision oncology clinical trials. Through a short documentary blending executive insight, advocate voices, and a family’s lived experience, we humanized complex science and demonstrated what putting patients first truly looks like—helping the company connect its innovation to compassion, courage, and real-world impact.
CORPORATE MISSION STATEMENT CASE STUDY
SHR partnered with a pioneering biotech company to translate a first-in-class oncology molecule into a clear, compelling mission story. Through a short documentary centered on the scientists behind the science, we transformed complex molecular biology into an accessible, emotionally grounded narrative—building trust, credibility, and understanding across investors, clinicians, advocates, and patients.